Genetic susceptibility to leishmanial infections: studies in mice and man
Author:
- 1 March 1996
- journal article
- research article
- Published by Cambridge University Press (CUP) in Parasitology
- Vol. 112 (S1) , S67-S74
Abstract
SUMMARY: Two important recent advances inLeishmaniaimmunology are: (i) the demonstration of a dramatic dichotomy in T helper 1 versus T helper 2 subset expansion leading to protection versus disease exacerbation; and (ii) analysis of the macrophage activation pathways leading to enhanced intracellular killing of parasites, in particular the tumour necrosis factor α (TNFα)-dependent sustained induction of the inducible nitric oxide synthase gene (Nos2) leading to the generation of large amounts of nitric oxide (NO). Given the broad spectrum of disease phenotypes in human leishmaniasis, one might predict that a genetic defect at any key point in this macrophage activation pathway and/or in pathways leading to activation of different T cell subsets, and the latter may be a pleiotropic effect of the former, will contribute to disease susceptibility. By studying disease in genetically-defined inbred mouse strains, it has been possible to identify 5 regions of the murine genome carrying leishmanial susceptibility genes. The genes include: (i)Scl-2(mouse chromosme 4/human chromosome 9p; candidate Janus tyrosine kinase 1) controlling a unique no lesion growth resistance phenotype toLeishmania mexicana; (ii)Scl-1(distal mouse chromosome 11/human 17q; candidatesNos2, Sigje, MIP1α, MIP1β) controlling healing versus non-healing responses toL. major; (iii) the ‘T helper 2’ cytokine gene cluster (proximal murine chromosome 11/human 5p; candidates IL4,5,9) controlling later phases ofL. majorinfection; (iv) the major histocompatibility complex (MHC: H-2 in mouse, HLA in man: mouse chromosome 17/human 6p; candidates class II and class III including TNFα/β genes); and (v)Nramp1, the positionally cloned candidate for the murine macrophage resistance geneIty/Lsh/Bcg(mouse chromosome 1/human 2q35). This review examines these 5 regions and the candidate genes within them, reflecting on their current status as candidates for human disease susceptibility genes.Keywords
This publication has 45 references indexed in Scilit:
- THE INDUCIBLE FORM OF NITRIC OXIDE SYNTHASE (NOS2) ISOLATED FROM MURINE MACROPHAGES MAPS NEAR THE NUDE MUTATION ON MOUSE CHROMOSOME 11European Journal of Immunogenetics, 1994
- Influence of macrophage resistance geneLsh/Ity/Bcg(candidateNramp) onToxoplasma gondiiinfection in miceClinical and Experimental Immunology, 1994
- NH2-terminal sequence of macrophage-expressed natural resistance-associated macrophage protein (Nramp) encodes a proline/serine-rich putative Src homology 3-binding domain.Journal of Experimental Medicine, 1994
- GENETIC CONTROL OF LEISHMANIA MAJOR INFECTION IN CONGENIC, RECOMBINANT INBRED AND F2 POPULATIONS OF MICEInternational Journal of Immunogenetics, 1993
- Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophagesEuropean Journal of Immunology, 1991
- Genetic regulation of macrophage priming/activation: the Lsh gene storyImmunology Letters, 1991
- Defining Protective Responses to Pathogens: Cytokine Profiles in Leprosy LesionsScience, 1991
- Immunogenetics of human american Cutaneous LeishmaniasisHuman Immunology, 1991
- Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector functionImmunology Today, 1991
- Influence of H–2 complex on acquired resistance to Leishmania donovani infection in miceNature, 1980